Kidney Disease Market to Grow at a CAGR of 6.5% to reach US$ 133,444.71 Million from 2020 to 2027

Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Diagnosis, Treatment); End User (Hospital, Diagnostic Laboratories, Others), and Geography

Publication Month: Sep 2020 | Report Code: TIPRE00014589 | No. of Pages: 215 | Category: Pharmaceuticals | Status: Published
Covid

The kidney disease market is expected to reach US$ 133,444.71 million by 2027 from US$ 81,128.11 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027.

 

Policy-makers have to ensure that an appropriate mix of pharmaceutical policy options is implemented to meet equitable, affordable, and sustainable access to medicines as well as medical care. The World Health Organization has projected various strategies to support policy-makers in developing suitable policies, including the concept of the vital medicine list and the universal health coverage (UHC) approach. Moreover, European countries with advanced UHC and social protection systems have developed pharmaceutical pricing and reimbursement systems that intend to offer various crucial medicines to their citizens at no or reduced cost. For instance, Armenia ensures 100% reimbursement for medicines for specific diseases such as TB, mental health diseases, diabetes, and chronic kidney failure.

 

In May 2019, VELTASSA, a prescription medication used to treat high potassium levels in the blood (hyperkalemia), has secured reimbursement in Germany, after the completion of AMNOG process (price negotiation and arbitration process). Moreover, reimbursement for the drug was secured in Finland, Austria, Portugal, Spain, Belgium, and a favorable recommendation was received from the National Institute for Health and Care Excellence in the UK. Furthermore, at the end of 2019, VELTASSA was launched in Sweden, Norway, Denmark, Belgium, Germany, Spain, The Netherlands, and Austria. Besides, in 2018, Vifor Pharma announced a licensing agreement with Zeria Pharmaceutical Co., Ltd. to catalyze the process of VELTASSA’s regulatory and reimbursement approval in Japan. Further, in December 2019, China’s National Healthcare Security Administration (NHSA) included Roxadustat in the updated National Reimbursement Drug List (NRDL). The drug Roxadustat is included in the NRDL for the treatment of anemia in CKD (Chronic Kidney Disease). Such lucrative reimbursement policies are likely to accelerate the growth of the market during the forecast period.

 

Lucrative Regional Markets for Kidney Disease

Lucrative Regional Markets for Kidney Disease

Get more information on this report :


 

Market Insights

High Prevalence of Chronic Diseases Leading to Kidney Diseases

Chronic kidney disease (CKD) is a common and life-threatening condition that affects 1 in 10 people worldwide. High blood pressure and diabetes were the two major causes in 75% of kidney failure cases between 2015 and 2017. Moreover, according to a study published by National Kidney Foundation in 2020, around 35.0% of the diabetic population above age 20 years would develop chronic kidney disease over the period of time.

As per the data published by National Kidney Foundation Inc., in 2020, CKD is likely to cause more deaths than prostate cancer or breast cancer. It is an under-recognized emergency health condition among people. 1 in 3 American adults (about 80 million people) is at risk due to CKD.

According to the estimates given by the Centers of Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. In 2015, 30.3 million people in the US had diabetes as per the American Diabetes Association. According to the CDC, in 2014, around 118,000 people in the US started the treatment for end-stage renal disease, and the number of people taking this treatment is expected to increase as more people become aware of this condition. Moreover, the CDC states that around 96% of the people with kidney damage are not aware of having chronic kidney disease, which indicates the underlying market prospective in the kidney disease market. These factors are expected to enhance market growth during the forecast period.


Product TypeInsights

Based on product type, the kidney disease market is segmented into diagnosis and treatment. In 2019, the diagnosis segment accounted for the largest share of the market. Growth of this segment is attributed to increase inblood tests, urine tests, and different imaging procedures.

 

Global Kidney Disease Market, by Product– 2019 and 2027

Global Kidney Disease Market, by Product– 2019 and 2027

Get more information on this report :


 

End UserInsights

Based on end user, the global kidney disease market is segmented into hospitals, diagnostic laboratories, and others. In 2019, the hospitals segment held a major share of the market and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

 

Strategic Insights

Product launches and approvalsare the commonly adopted strategies by companies to expand their global footprintsand product portfolios tomeet the growing consumer demand. The kidney disease marketplayers adopt the collaborationsstrategy to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

 

Kidney Disease Market– by Product Type

  •      Diagnosis
    •     Blood Tests
    •     Urine Tests
    •     Imaging Tests
    •     Others
  •   Treatment
    •   Drug Class
      •   ACE Inhibitors
      •   Angiotensin-II Receptor Blockers
      •   Diuretics
      •   Others

Kidney Disease Market– by End User

  •      Hospitals
  •      Diagnostic Laboratories
  •      Others

Kidney Disease Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East &Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East &Africa
  • South and Central America
    • Brazil
    • Argentina
    • Rest of South America

 

Company Profiles

  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • AbbVie's Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Amgen Inc.
  • Sysmex Corp.
  • Fresenius Medical Care SE & Co. KGaA
  • Siemens Healthineers AG

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Kidney Disease Market – By Product Type

1.3.2        Kidney Disease Market – By End User

1.3.3        Global Kidney Disease Market – By Geography

2.             Kidney Disease Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Kidney Disease– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.             Kidney Disease Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        High Prevalence of Chronic Diseases Leading to Kidney Diseases

5.1.2        Favorable Reimbursement Policy for Kidney Disease Treatments

5.2       Market Restraints

5.2.1        Undiagnosed Cases of Kidney Disease

5.3       Market Opportunities

5.3.1        Increase in Preference for Robotic Surgeries for Kidney Diseases

5.4       Future Trends

5.4.1        Rise in Preference for Advanced Hemodialysis Therapies

5.5       Impact Analysis

6.             Kidney Disease Market – Global Analysis

6.1       Global Kidney Disease Marker Revenue Forecast And Analysis

6.2       Global Kidney Disease Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Kidney Disease Market Analysis – By Product Type

7.1       Overview

7.2       Kidney Disease Market Revenue Share, by Product Type (2019 and 2027)

7.3       Diagnosis

7.3.1        Overview

7.3.2        Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.3        Blood Tests

7.3.3.1      Overview

7.3.3.2      Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027(US$ Million)

7.3.4        Urine Tests

7.3.4.1      Overview

7.3.4.2      Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.5        Imaging Tests

7.3.5.1      Overview

7.3.5.2      Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.6        Others

7.3.6.1      Overview

7.3.6.2      Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Treatment

7.4.1        Overview

7.4.2        Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3        Drug Class

7.4.3.1      Overview

7.4.3.2      Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.1       ACE Inhibitors

7.4.3.2.1.1           Overview

7.4.3.2.1.2           ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.2       Angiotensin-II Receptor Blockers

7.4.3.2.2.1           Overview

7.4.3.2.2.2           Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.3       Diuretics

7.4.3.2.3.1           Overview

7.4.3.2.3.2           Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.4       Others

7.4.3.2.4.1           Overview

7.4.3.2.4.2           Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.4        Dialysis

7.4.4.1      Overview

7.4.4.2      Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.5        Others

7.4.5.1      Overview

7.4.5.2      Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.             Kidney Disease Market Analysis – By End User

8.1       Overview

8.2       Kidney Disease Market Revenue Share, by End User (2019 and 2027)

8.3       Hospitals

8.3.1        Overview

8.3.2        Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Diagnostic Laboratories

8.4.1        Overview

8.4.2        Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Others

8.5.1        Overview

8.5.2        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

9.             Kidney Disease Market Analysis and Forecasts To 2027 – Geographical Analysis

9.1       North America: Kidney Disease Market

9.1.1        Overview

9.1.2        North America: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.1      North America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.3.2      North America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.3.2.1       North America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.4        North America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.5        North America: Kidney Disease Market, by Country, 2019 & 2027 (%)

9.1.6        US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1      US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2      US: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.1       US: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2       US: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2.1           US: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.6.3      US: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.7        Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1      Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2      Canada: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.1       Canada: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2       Canada: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2.1           Canada: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.7.3      Canada: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.8        Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1      Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2      Mexico: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.1       Mexico: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2       Mexico: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2.1           Mexico: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.8.3      Mexico: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.2       Europe: Kidney Disease Market

9.2.1        Overview

9.2.2        Europe: Kidney Disease Market, - Revenue and Forecast to 2027 (USD Million)

9.2.3        Europe: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.2.3.1      Europe: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.2.3.2      Europe: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.2.3.2.1       Europe: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.2.4        Europe: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.2.5        Europe: Kidney Disease Market, by Country, 2019 & 2027 (%)

9.2.6        Germany: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.6.1      Germany: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.6.2      Germany: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.2.6.2.1       Germany: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.2.6.2.2       Germany: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.2.6.2.2.1           Germany: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.2.6.3      Germany: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.2.7        UK: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.7.1      UK: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.7.2      UK: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.2.7.2.1       UK: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.2.7.2.2       UK: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.2.7.2.2.1           UK: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.2.7.3      UK: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.2.8        France: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.8.1      France: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.8.2      France: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.2.8.2.1       France: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.2.8.2.2       France: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.2.8.2.2.1           France: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.2.8.3      France: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.2.9        Italy: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.9.1      Italy: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.9.2      Italy: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.2.9.2.1       Italy: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.2.9.2.2       Italy: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.2.9.2.2.1           Italy: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.2.9.3      Italy: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.2.10     Spain: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.10.1    Spain: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.2.10.2    Spain: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.2.10.2.1    Spain: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.2.10.2.2    Spain: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.2.10.2.2.1        Spain: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.2.10.3    Spain: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.3       Asia Pacific: Kidney Disease Market

9.3.1        Overview

9.3.2        Asia Pacific: Kidney Disease Market, - Revenue and Forecast to 2027 (USD Million)

9.3.2.1      Canada: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.3.2.1.1       Asia Pacific: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.3.2.1.2       Asia Pacific: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.3.2.1.2.1           Asia Pacific: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.3.2.2      Asia Pacific: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.3.3        Asia Pacific: Kidney Disease Market, by Country, 2019 & 2027 (%)

9.3.4        Japan: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.4.1      Japan: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.4.2      Japan: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.3.4.2.1       Japan: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.3.4.2.2       Japan: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.3.4.2.2.1           Japan: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.3.4.3      Japan: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.3.5        China: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.5.1      China: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.5.2      China: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.3.5.2.1       China: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.3.5.2.2       China: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.3.5.2.2.1           China: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.3.5.3      China: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.3.6        India: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.1      India: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.2      India: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.3.6.2.1       India: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.3.6.2.2       India: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.3.6.2.2.1           India: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.3.6.3      India: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.3.7        South Korea: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.1      South Korea: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.2      South Korea: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.3.7.2.1       South Korea: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.3.7.2.2       South Korea: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.3.7.2.2.1           South Korea: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.3.7.3      South Korea: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.3.8        Australia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.1      Australia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.2      Australia: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.3.8.2.1       Australia: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.3.8.2.2       Australia: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.3.8.2.2.1           Australia: Kidney Disease Market, by Drug Class– Revenue and Forecast to 2027 (USD Million)

9.3.8.3      Australia: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.4       Middle East & Africa: Kidney Disease Market

9.4.1        Overview

9.4.2        Middle East & Africa: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)

9.4.3        Middle East and Africa: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.4.3.1      Middle East and Africa: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.4.3.2      Middle East and Africa: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.4.3.2.1       Middle East and Africa: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.4.4        Middle East and Africa: Kidney Disease Market, by End User – Revenue and Forecast to 2027  (USD Million)

9.4.5        Middle East & Africa: Kidney Disease Market, by Country, 2019& 2027 (%)

9.4.6        Saudi Arabia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.1      Saudi Arabia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.2      Saudi Arabia: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.4.6.2.1       Saudi Arabia: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.4.6.2.2       Saudi Arabia: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.4.6.2.2.1           Saudi Arabia: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.4.6.3      Saudi Arabia: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.4.7        UAE: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.1      UAE: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.2      UAE: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.4.7.2.1       UAE: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.4.7.2.2       UAE: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.4.7.2.2.1           UAE: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.4.7.3      UAE: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.4.8        South Africa: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.4.8.1      South Africa: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.4.8.2      South Africa: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.4.8.2.1       South Africa: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.4.8.2.2       South Africa: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.4.8.2.2.1           South Africa: Kidney Disease Market, by Drug Class– Revenue and Forecast to 2027 (USD Million)

9.4.8.3      South Africa: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.5       South and Central America: Kidney Disease Market

9.5.1        Overview

9.5.2        South and Central America: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.5.3        South and Central America: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.5.3.1      South and Central America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.5.3.2      South and Central America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.5.3.2.1       South and Central America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.5.4        South and Central America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.5.5        South and Central America: Kidney Disease Market, by Country, 2019 & 2027 (%)

9.5.6        Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.1      Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.2      Brazil: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.5.6.2.1       Brazil: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.5.6.2.2       Brazil: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.5.6.2.2.1           Brazil: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.5.6.3      Brazil: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.5.7        Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.1      Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.2      Argentina: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.5.7.2.1       Argentina: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.5.7.2.2       Argentina: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.5.7.2.2.1           Argentina: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.5.7.3      Argentina: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.          Impact of COVID-19 Pandemic on Global Kidney Disease Market

10.1    North America: Impact Assessment of COVID-19 Pandemic

10.2    Europe: Impact Assessment of COVID-19 Pandemic

10.3    Asia Pacific: Impact Assessment of COVID-19 Pandemic

10.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

11.          Kidney Disease Market – Industry Landscape

11.1    Overview

11.2    Growth Strategies Done by the Companies in the Market, (%)

11.3    Organic Developments

11.3.1     Overview

11.4    Inorganic Developments

11.4.1     Overview

12.          Company Profiles

12.1    Abbott

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    F. HOFFMANN-LA ROCHE LTD.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    AbbVie Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Pfizer Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    TEVA PHARMACEUTICAL INDUSTRIES LTD

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    GlaxoSmithKline plc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Amgen Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Sysmex Corporation

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Fresenius SE & Co. KGaA

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Siemens AG

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Products and Services

12.10.4   Financial Overview

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.          Appendix

13.1    Glossary of Terms

LIST OF TABLES

Table 1.             North America: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 9.             US: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.          US: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 13.          Canada: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 18.          Mexico: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Europe: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 22.          Europe: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 23.          Europe: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 24.          Europe: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 25.          Europe: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 26.          Germany: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 27.          Germany: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 28.          Germany: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 29.          Germany: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 30.          Germany: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31.          UK: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 32.          UK: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 33.          UK: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 34.          UK: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 35.          UK: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 36.          France: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 37.          France: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 38.          France: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 39.          France: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 40.          France: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 41.          Italy: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 42.          Italy: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 43.          Italy: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 44.          Italy: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 45.          Italy: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 46.          Spain: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 47.          Spain: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 48.          Spain: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 49.          Spain: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 50.          Spain: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 51.          Canada: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 52.          Asia Pacific: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 53.          Asia Pacific: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 54.          Asia Pacific: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 55.          Asia Pacific: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 56.          Japan: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 57.          Japan: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 58.          Japan: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 59.          Japan: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 60.          Japan: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 61.          China: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 62.          China: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 63.          China: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 64.          China: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 65.          China: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 66.          India: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 67.          India: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 68.          India: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 69.          India: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 70.          India: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 71.          South Korea: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 72.          South Korea: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 73.          South Korea: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 74.          South Korea: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 75.          South Korea: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 76.          Australia: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 77.          Australia: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 78.          Australia: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 79.          Australia: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 80.          Australia: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 81.          Middle East and Africa: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 82.          Middle East and Africa: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 83.          Middle East and Africa: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 84.          Middle East and Africa: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 85.          Middle East and Africa: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 86.          Saudi Arabia: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 87.          Saudi Arabia: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 88.          Saudi Arabia: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 89.          Saudi Arabia: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 90.          Saudi Arabia: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 91.          UAE: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 92.          UAE: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 93.          UAE: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 94.          UAE: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 95.          UAE: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 96.          South Africa: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 97.          South Africa: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 98.          South Africa: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 99.          South Africa: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 100.       South Africa: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 101.       South and Central America: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 102.       South and Central America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 103.       South and Central America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 104.       South and Central America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 105.       South and Central America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 106.       Brazil: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 107.       Brazil: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 108.       Brazil: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 109.       Brazil: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 110.       Brazil: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 111.       Argentina: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 112.       Argentina: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 113.       Argentina: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 114.       Argentina: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 115.       Argentina: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 116.       Organic Developments Done By Companies

Table 117.       Inorganic Developments Done By Companies

Table 118.       Glossary of Terms, Kidney Disease Market

 

LIST OF FIGURES

Figure 1.           Kidney Disease Market Segmentation

Figure 2.           Kidney Disease Market – By Geography

Figure 3.           Kidney Disease Market Overview

Figure 4.           Diagnosis Segment Held Largest Share of Kidney Disease Market

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           Kidney Disease Market, by Geography (US$ Million)

Figure 7.           Global Kidney Disease Market – Leading Country Markets (US$ Million)

Figure 8.           Global Kidney Disease Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America (SCAM) PEST Analysis

Figure 14.        Kidney Disease Market Impact Analysis of Drivers and Restraint

Figure 15.        Global Kidney Disease Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Kidney Disease Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Kidney Disease Market

Figure 18.        Kidney Disease Market Revenue Share, by Product Type (2019 and 2027)

Figure 19.        Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Kidney Disease Market Revenue Share, by End User (2019 and 2027)

Figure 33.        Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        North America: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)

Figure 37.        North America: Kidney Disease Market Revenue and Forecast to 2027 (USD Million)

Figure 38.        North America: Kidney Disease Market, by Country, 2019 & 2027 (%)

Figure 39.        US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 40.        Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        Europe: Kidney Disease Market , by Key Country – Revenue (2019) (USD Million)

Figure 43.        Europe: Kidney Disease Market, Revenue and Forecast to 2027 (USD Million)

Figure 44.        Europe: Kidney Disease Market, by Country, 2019 & 2027 (%)

Figure 45.        Germany: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 46.        UK: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 47.        France: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 48.        Italy: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        Spain: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        Asia Pacific: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)

Figure 51.        Asia Pacific: Kidney Disease Market, Revenue and Forecast to 2027 (USD Million)

Figure 52.        Asia Pacific: Kidney Disease Market, by Country, 2019 & 2027 (%)

Figure 53.        Japan: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 54.        China: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        India: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 56.        South Korea: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Australia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 58.        Middle East & Africa: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)

Figure 59.        Middle East & Africa Kidney Disease Market Revenue and Forecast to 2027 (USD Million)

Figure 60.        Middle East & Africa: Kidney Disease Market, by Country, 2019& 2027 (%)

Figure 61.        Saudi Arabia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 62.        UAE: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 63.        South Africa: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        South and Central America: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)

Figure 65.        South and Central America Kidney Disease Market Revenue and Forecast to 2027 (USD Million)

Figure 66.        South and Central America: Kidney Disease Market, by Country, 2019 & 2027 (%)

Figure 67.        Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 68.        Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 69.        Impact of COVID-19 Pandemic on Kidney Disease Market in North American Countries

Figure 70.        Impact of COVID-19 Pandemic on Kidney Disease Market in European Countries

Figure 71.        Impact of COVID-19 Pandemic on Kidney Disease Market in Asia Pacific Countries

Figure 72.        Impact of COVID-19 Pandemic on Kidney Disease Market in Rest of the World

Figure 73.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Kidney Disease Market

  1. Abbott
  2. F. Hoffmann-La Roche Ltd.
  3. AbbVie's Inc.
  4. Pfizer Inc.
  5. Teva Pharmaceutical Industries Ltd.
  6. GlaxoSmithKline plc
  7. Amgen Inc.
  8. Sysmex Corp.
  9. Fresenius Medical Care SE & Co. KGaA
  10. Siemens Healthineers AG

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Kidney disease market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global percutaneous mechanical circulatory support devices  market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00014589
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing